Skip to main content
IC
Britannia Life Sciences Inc. (CSE:BLAB)
Canada flag Canada · Delayed Price · Currency is CAD
0.0700
-0.0150 (-20.00%)
May 9, 2025, 9:46 AM EDT

Britannia Life Sciences Cash Flow Statement

Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Net Income
-4.775.08-15.46-0.16-0.63
Depreciation & Amortization
0.230.160.190.04-
Other Amortization
0.10.0700-
Loss (Gain) From Sale of Assets
-0.47-1.39---
Loss (Gain) on Equity Investments
0.960.020--
Stock-Based Compensation
0.231.051.11--
Other Operating Activities
4.93-2.5716.50.22-0.01
Change in Accounts Receivable
0.560.2-0.1-0.24-0.02
Change in Inventory
0.07----
Change in Accounts Payable
0.24-0.650.62-0.450.17
Change in Other Net Operating Assets
0.010.04-0.05--
Operating Cash Flow
2.092.012.8-0.59-0.5
Operating Cash Flow Growth
4.15%-28.26%---
Capital Expenditures
-0.13-0.06-0.090.04-
Cash Acquisitions
-1.1-2.980.74-4.96-
Sale (Purchase) of Intangibles
-0.2-0.29---
Investing Cash Flow
-1.44-3.320.65-4.91-
Short-Term Debt Issued
0.03-0.120.23-
Long-Term Debt Issued
-7.981.416-
Total Debt Issued
0.037.981.536.22-
Short-Term Debt Repaid
--4.96-3.44--
Long-Term Debt Repaid
-2-0.07-0.08-0.02-
Total Debt Repaid
-2-5.03-3.52-0.02-
Net Debt Issued (Repaid)
-1.972.95-1.996.2-
Issuance of Common Stock
--0-0.66
Other Financing Activities
--0.79-0.6-0-0.01
Financing Cash Flow
-1.972.16-2.586.20.65
Foreign Exchange Rate Adjustments
0.050.13-0.07-0.02-
Net Cash Flow
-1.280.970.80.690.15
Free Cash Flow
1.961.952.71-0.54-0.5
Free Cash Flow Growth
0.19%-27.99%---
Free Cash Flow Margin
25.85%30.50%37.16%-38.15%-
Free Cash Flow Per Share
0.010.010.03-0.01-0.08
Cash Interest Paid
-0.79---
Levered Free Cash Flow
6.160.431.790.41-
Unlevered Free Cash Flow
6.960.963.240.63-
Change in Net Working Capital
-5.940.6-1.02-0.37-
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.